Activation of NF-κB, p38 and MAPK pathways, increased levels of IFN γ, TNFα, MCP-1, IL-1β and IL-6 and adipokines leading to insulin resistance and of concomitant metabolic alterations. This evidence concerns the gene TNF and Insulin resistance.